0001691275-17-000001.txt : 20170602 0001691275-17-000001.hdr.sgml : 20170602 20170601202423 ACCESSION NUMBER: 0001691275-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170601 EFFECTIVENESS DATE: 20170602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Expansion Therapeutics, Inc. CENTRAL INDEX KEY: 0001691275 IRS NUMBER: 814414709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-275680 FILM NUMBER: 17886195 BUSINESS ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: (650) 430-5836 MAIL ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 D/A 1 primary_doc.xml X0707 D/A LIVE 0001691275 Expansion Therapeutics, Inc. 491 PINE NEEDLES DRIVE DEL MAR CA CALIFORNIA 92014 (650) 430-5836 DELAWARE None None Corporation true 2016 Kevin Forrest c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Executive Officer Director Matthew Disney c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Director Scott Rocklage 501 2nd Street, #350 San Francisco CA CALIFORNIA 94107 Executive Officer Director Paul Stone 501 2nd Street, #350 San Francisco CA CALIFORNIA 94107 Executive Officer Yujiro Hata c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Director Jason Hafler 55 Corporate Drive Bridgewater NJ NEW JERSEY 08807 Director Pharmaceuticals Decline to Disclose 06b true 0001691275-16-000001 2016-11-28 false true true Consists of Convertible Promissory Notes convertible into shares of preferred stock of the Issuer. false 0 5000000 5000000 0 false 3 0 0 0 false Expansion Therapeutics, Inc. /s/ Kevin Forrest, Ph.D. Kevin Forrest, Ph.D. President and Chief Executive Officer 2017-05-31